UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549



FORM 10-Q / A

(Mark One)



X  .
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



For the quarterly period ended June 30, 2011

or



.
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



For the transition period from _________ to
__________



Commission File Number: 000-53089



CHINA NORTHERN MEDICAL DEVICE, INC.

(Exact name of registrant as specified in its
charter)



|                                                               |  |                                     
|-------------------------------------------------------------- |  | ------------------------------------
|NEVADA                                                         |  | 30-0428006                          
|(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employee Identification No.)



|                                                                                                 |  |           
|------------------------------------------------------------------------------------------------ |  | ----------
|70 DAXIN JIE, DAOWAI DISTRICT
        HAERBING CITY,
        HEILONGJIANG PROVINCE
        CHINA |  | 150020    
|(Address of principal executive offices)                                                         |  | (Zip Code)



(86) 451- 8228-0845

(Registrant’s telephone number,
including area code)



Not Applicable

(Former name, former address and former fiscal
year, if changed since the last report)



Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days.

Yes X
 . No .



Indicate by check mark whether the registrant has submitted electronically
and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit and post such files).

Yes .
No .



Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated
filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.



|                        |                                                |                           |    
|----------------------- | ---------------------------------------------- | ------------------------- | ---
|Large accelerated filer | .                                              | Accelerated filer         | .  
|Non-accelerated filer   | .(Do not check if a smaller reporting company) | Smaller reporting company | X .



Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act).

Yes X
 . No .



Indicate the number of shares outstanding of each of the issuer’s
classes of common equity, as of the latest practicable date. 3,550,000 shares of common stock were issued and outstanding as of
August 8, 2011.







EXPLANATORY
NOTE



The purpose of the Amendment No.
1 on Form 10-Q/A to China Northern Medical Device Inc.'s Quarterly Report of Form 10-Q for the quarter ended June 30, 2011, filed
with the Securities and Exchange Commission on August 14, 2011 (the "Form 10-Q"), is solely to furnish Exhibit 101 to
the Form 10-Q in accordance with Rule 405 of Regulation S-T. No other changes have been made
to the Form 10-Q.



Pursuant to Rule 406T of Regulation
S-T, the interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for
purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the
Securities Act of 1934, as amended, and otherwise are not subject to liability under those sections.





China Northern Medical Device Inc

Dated: September 8, 2011

By:



|: | /s/ Jinzhao Wu                                                           | 
|- | ------------------------------------------------------------------------ | 
|  | Jinzhao Wu                                                              
|  | President, Chief Executive Officer,
        Principal Accounting Officer